- Research Article
- Open access
- Published:
24-h ambulatory pulse wave velocity and central blood pressure in type 2 diabetes
Artery Research volume 8, pages 73–79 (2014)
Abstract
Background
Pulse wave analysis from a brachial cuff permits ambulatory measurements of pulse wave velocity (PWV) and central blood pressure parameters. The diurnal variation of PWV in type 2 diabetes is unknown.
Methods
We evaluated the Arteriograph24 which is a brachial cuff based equipment for estimating PWV and central blood pressure data without the use of a transfer function, in 22 type 2 diabetic patients, who had two 24 h measurements performed.
Results
The mean number of valid day time and nighttime measurements were 29 (range 16–50) and 18 (11–25), respectively. 21 patients had at least one qualifying report. Nighttime PWV was significantly lower than during the day (9.1 vs. 9.7 ± 0.8 mm/s, p < 0.01). Systolic aortic blood pressure was 6 mmHg lower than brachial blood pressure in the day time (p < 0.01) and 4 mmHg lower during the night (p < 0.05). Each single measurement was standardized with the 24 h average as reference thus generating data from 1004 paired observations. The standardized PWV correlated with standardized values of heart rate (r = 0.24, p < 0.001) and systolic aorta blood pressure (r = 0.20, p < 0.001). A stepwise multiple regression model with standardized pulse wave velocity as dependent variable included standardized heart rate, systolic aorta blood pressure and a dummy variable for day/night status (R2 = 0.091, p < 0.001).
Conclusion
The Arteriograph24 is applicable for research purpose. PVW in type 2 diabetes is modestly reduced during the night. The intraindividual variation of heart rate contributed independently to the variation of PWV.
References
Nilsson PM, Booutyrie P, Laurent S. Vascular ageing: a tale of EVA and ADAM in cardiovascular risk assessment and hypertension. Hypertension 2009;54:3–10.
Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006;113:664–70.
Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse- wave velocity and its relation to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002;106:2085–90.
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318–27.
Cardoso CRL, Ferreira MT, Leite NC, Salles GF. Prognostic impact of aortic stiffness in high-risk type 2 diabetic patients. Diabetes Care 2013;36:3772–8.
Ben-Shlomo Y, Spears M, Boustred C, May M, Andersen SG, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol; 2013:636–46. https://doi.org/10.1016/jacc.2013.09.063.
Baulmann J, Schillings U, Rickert S, Uen S, Düsing R, Illyes M, et al. A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. J Hypertens 2008;26:523–8.
Segers P, Kips J, Swillens A, Vermeersch S, Mahieu D, Rietzschel E, et al. Limitations and pitfalls of non-invasive measurements of arterial pressure wave reflections and pulse wave velocity. Artery Res 2009;3:79–88.
Boutouyrie P, Revera M, Parati G. Obtaining arterial stiffness indices from simple arm cuff measurements the holy grail ? J Hypertens 2009;27:2159–61.
Parati G, De Buyzere M. Evaluating aortic stiffness through an arm cuff oscillometric device: is validation against invasive measurements enough? J Hypertens 2010;28:2003–6.
Rajzer MW, Wojciechowska W, Klocek M, Palka I, Brozozowska-Kiszka M, Kawecka-Jaszcz K. Comparison of aortic pulse wava velocity measured by three techniques. Complior, Sphygmocor and Arteriograph. J Hypertens 2008;26:2001–7.
Jatoi NA, Mahmud A, Bennett K, Fely J. Assessment of arterial stiffness in hypertension. comparison of oscillometric (Arteriograph) piezoelectronic (Complior) and tonometric (Sphygmocor) techniques. J Hypertens 2009;27:2186–91.
Rezai M-R, Cowan BR, Sherratt N, Finn JD, Wu FCW, Cruickshank JK. A magnetic resonance perspective of the pulse wave transit time by the arteriograph device and potential for improving aortic length estimation for central pulse wave velocity. Blood Press Monit 2013;18:111–8.
Kahan T, Boutouyrie P, Cziraki A, Illyés M, Laurent S, Monar FT, et al. Aortic stiffness measured by a novel oscillometric method independently predicts cardiovascular morbidity and mortality: a study of 4146 subjects. J Hypertens 2013;31(e-suppl A):e102.
Horváth IG, Németh A, Lenky Z, et al. Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 2010;28:2068–75.
Rossen NB, Laugesen E, Peters CD, Ebbehøj E, Knudsen ST, Poulsen PL, et al. Invasive validation of arteriograph estimates of central blood pressure in patients with type 2 diabetes. Am J Hypertens 2014;27(5):674–9.
ÓBrien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013;31:1731–68.
Nemeth Z, Moczar K, Deak G. Evaluation of the tensioday ambulatory blood pressure monitor according to the British Hypertension Society and the Association for the Advancement of Medical Instrumentation. Blood Press Monit 2002;7:191–7.
O’Brien E, Asmar R, Beilin L, Imai Y, Maillon JM, Mancia G, et al. European society of hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821–48.
Laugesen E, Høyem P, Stausbøl-Grøn B, Mikkelsen A, Thrysøe S, Erlandsen M, et al. Carotid-femoral pulse wave velocity is associated with cerebral white matter lesions in type 2 diabetes. Diabetes Care 2013;36:722–8.
Agnoletti D, Lieber A, Zhang Y, Protogerau AD, Borghi C, Blacher J, et al. Central hemodynamic modification in diabetes mellitus. Atheroslerosis 2013;230:315–21.
Luzardo L, Lujambio I, Sottolano M, de Rosa A, Thijs L, Noboa O, et al. 24-h ambulatory recording of aortic pulse wave velocity and central augmentation index: a feasibility study. Hypertens Res 2012;35:980–7.
McEniery CM, Yasmin, McDonnel B, Munnery M, Wallace SM, Rowe CV, et al. Central pressure: variability and impact of cardiovascular risk factors. Hypertension 2008;51:1476–82.
ÓRourke MF, Hayward CS. Arterial stiffness, gender and heart rate. J Hypertens 2003;21:487–90.
Lantelme P, Mestre C, Lievre M, Gressard, Milon H. Heart rate, an important confounder of pulse wave velocity assessment. Hypertension 2002;39:1083–7.
Millesseau SC, Stewart AD, Patel SJ, Redwood SR, Chowienczyk PJ. Evaluation of carotid-femoral pulse wave velocity. Influence of timing algorithm and heart rate. Hypertension 2005;45:222–6.
Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, et al. Heart rate dependency of pulse rate amplification and arterial stiffness. Am J Hypertens 2002;15:24–30.
Papaioannou TG, Argyris A, Protogerou AD, Vrachatis D, Nasothimiou EG, Sfikakis PP, et al. Non-invasive 24 hour ambulatory monitoring of aortic wave reflection and arterial stiffness by a novel oscillometric device: the first feasibility and reproducibility study. Int J Cardiol 2013;25:57–61.
Wilkinson IB, Fuchs S, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998;16:2079–84.
Frimodt-Møller M, Nielsen AH, Kamper A-L, Strandgaard S. Pulse–wave morphology and pulse-wave velocity in healthy human volunteers: examination conditions. Scand J Clin Lab Invest 2006;66:385–94.
Frimodt-Møller M, Nielsen AH, Kamper A-L, Strandgaard S. Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease. Nephrol Dial Transplant 2008;23:594–600.
Leewen Segarceanu EM, Tromp WF, Bos W-JW, Vogels OJM, Groothoff JW, van der Lee JH. Comparison of two instruments measuring carotid-femoral pulse wave velocity: Vicorder versus Sphygmocor. J Hypertens 2010; :1687–91.
(a) Laugesen E, Rossen NB, Høyem P, Christiansen JS, Knudsen ST, Hansen KW, et al. Reproducibility of pulse wave analysis and pulse wave velocity in patients with type 2 diabetes. Scand J Clin Lab Invest 2013;73:428–35; (b) Conway J, Coats A. Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens 1989; 7(Suppl. 3):S29–32.
Weber T, McEniery C, Wilkinson I, Schillaci G, Muiesan ML, Zweiker R, et al. Relationship between 24h ambulatory central blood pressure and left ventricular mass- rationale and design of a prospective multicenter study. Artery Res 2012;6:103–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
About this article
Cite this article
Krogager, C., Rossen, N.B., Laugesen, E. et al. 24-h ambulatory pulse wave velocity and central blood pressure in type 2 diabetes. Artery Res 8, 73–79 (2014). https://doi.org/10.1016/j.artres.2014.04.004
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.artres.2014.04.004